À propos du livre
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.
Format PDF
-
Nb pages copiables
:
2
-
Nb pages imprimables
:
24
-
Poids
:
5120 Ko
-
-
Prix
:
149,79 €
- EAN :
9783319679327